Abstract
Outcomes of Transplant-Eligible Newly Diagnosed Ultra-High Risk Myeloma Patients Treated in the NCRI Myeloma XI Trial Indicate the Need for Early Treatment Stratification and Novel Treatment Approaches
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have